← All UWorld Flashcard Decks

Biostatistics and Epidemiology Flashcards

7 cards from real UWorld practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Biostatistics and Epidemiology flashcards as text
  1. A screening test has 90% sensitivity and 80% specificity and is used in 1,000 people with a disease prevalence of 10%. What is the positive predictive value?

    Answer: About 33%

    TP = 90 and FP = 180, so PPV = 90/270 ≈ 33%.

  2. The cutoff for a positive fasting glucose screening test is lowered from 126 mg/dL to 110 mg/dL. Which change is expected?

    Answer: Sensitivity increases and specificity decreases

    A lower cutoff labels more people positive, so there are fewer false negatives and more false positives.

  3. A test has a sensitivity of 90% and a specificity of 80%. What is its positive likelihood ratio?

    Answer: 4.5

    LR+ = sensitivity / (1 − specificity) = 0.9/0.2 = 4.5.

  4. A test with unchanged sensitivity and specificity is moved from a community clinic to a specialty referral center, where disease prevalence is much higher. What happens to its predictive values?

    Answer: PPV increases and NPV decreases

    Higher prevalence raises PPV and lowers NPV, while sensitivity and specificity stay the same.

  5. A physician wants to rule out a dangerous condition with a single test. Which test property matters most when the result is negative?

    Answer: High sensitivity

    A negative result on a highly sensitive test reliably rules disease out (SnNout).

  6. A new screening program shows that patients diagnosed by screening survive 2 years longer after diagnosis, but the age at death does not change. Which bias best explains this?

    Answer: Lead-time bias

    Earlier detection starts the survival clock sooner without delaying death.

  7. A screening program mostly detects slow-growing, indolent tumors, which makes screening look more beneficial than it really is. What is this bias?

    Answer: Length-time bias

    Slowly progressing disease spends longer in the detectable preclinical phase, so screening catches it more often.

How this page was made: written with AI tools. We have not yet matched this exam's facts to an official source, so confirm fees, dates and rules with the exam body. Not reviewed by a subject-matter expert. Editorial policy